US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Galmed Pharmaceuticals

4.31

-0.2550-5.59%

Post-market: 4.15-0.1550-3.60%19:30 EDT

Volume:22.21K

Turnover:95.79K

Market Cap:4.48M

PE:-0.27

High:4.54

Open:4.54

Low:4.12

Close:4.56

52wk High:13.20

52wk Low:3.29

Shares:1.04M

Float Shares:1.01M

Volume Ratio:0.22

T/O Rate:2.21%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-16.1401

EPS(LYR):-19.1292

ROE:-72.12%

ROA:-33.45%

PB:0.32

PE(LYR):-0.23

Loading ...

Overview Company News Filings

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Galmed Pharmaceuticals (GLMD), Neurocrine (NBIX) and Mesoblast (MESO)

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Nano-X, Travere

Galmed Pharmaceuticals Teams with Tel Aviv University on Aramchol for Metastatic Brain Cancer

Galmed partners with Tel Aviv University to test Aramchol in brain metastases

Galmed Announces a Collaboration Agreement With Tel Aviv University to Evaluate Its Scd1 Inhibitor, Aramchol, as a Targeted Therapy for Metastatic Brain Cancers

THOMSON REUTERS

BUZZ-U.S. STOCKS ON THE MOVE-Amazon, Northrop Grumman, Brown-Forman

Why Is Galmed Pharmaceuticals Stock (GLMD) Up Today?

BUZZ-Galmed jumps on lab data on new brain-penetrating version of experimental drug

Galmed Pharmaceuticals Ltd - Develops Brain-Penetrating Formulation of Aramchol With Barcode Nanotech

THOMSON REUTERS

Galmed plans Phase 1b/2 Parkinson’s trial for brain-penetrating Aramchol in H2 2026

Galmed net loss widens 37% to $10 million in FY25

Galmed Pharmaceuticals Ltd expected to post a loss of 51 cents a share - Earnings Preview

Galmed Pharmaceuticals Ltd. CFO Doron Leib Cohen files initial beneficial ownership statement

Galmed Pharmaceuticals COO Nehemya Guy files initial beneficial ownership statement

Galmed Pharmaceuticals names Chief Accounting Officer Yohai Stenzler in initial beneficial ownership filing

Galmed Pharmaceuticals Director Carol L. Brosgart Files Initial Beneficial Ownership Statement

Galmed Pharmaceuticals names CEO Allen Baharaff in initial beneficial ownership filing

Galmed Pharmaceuticals Adjourns Special Shareholder Meeting for Lack of Quorum

Galmed Pharmaceuticals Delays Shareholder Meeting to March 5

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/GLMD/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GLMD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLMD\",,,,,undefined,":{"symbol":"GLMD","market":"US","secType":"STK","nameCN":"Galmed Pharmaceuticals","latestPrice":4.305,"timestamp":1787342400000,"preClose":4.56,"halted":0,"volume":22210,"hourTrading":{"tag":"盘后","latestPrice":4.15,"preClose":4.305,"latestTime":"19:30 EDT","volume":606,"amount":2517.1086,"timestamp":1787355005364,"change":-0.155,"changeRate":-0.036005,"amplitude":0.036353},"delay":0,"changeRate":-0.05592105263157893,"floatShares":1006212,"shares":1041600,"eps":-16.140087,"marketStatus":"Market Closed","change":-0.255,"latestTime":"08-21 16:00:00 EDT","open":4.54,"high":4.54,"low":4.12,"amount":95788.589506,"amplitude":0.092105,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-16.140087,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1394683200000,"exchange":"NASDAQ","adjPreClose":4.56,"postHourTrading":{"tag":"盘后","latestPrice":4.15,"preClose":4.305,"latestTime":"19:30 EDT","volume":606,"amount":2517.1086,"timestamp":1787355005364,"change":-0.155,"changeRate":-0.036005,"amplitude":0.036353},"volumeRatio":0.22100646034362878,"impliedVol":0.7031,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLMD\",,,,,undefined,":{"symbol":"GLMD","floatShares":1006212,"roa":"-33.45%","roe":"-72.12%","lyrEps":-19.12916,"volumeRatio":0.22100646034362878,"shares":1041600,"dividePrice":0,"high":4.54,"amplitude":0.092105,"preClose":4.56,"low":4.12,"week52Low":3.2888,"pbRate":"0.32","week52High":13.2,"institutionHeld":0,"latestPrice":4.305,"eps":-16.140087,"divideRate":0,"volume":22210,"delay":0,"ttmEps":-16.140087,"open":4.54,"prevYearClose":6.004,"prevWeekClose":4.1848,"prevMonthClose":4.968,"prevQuarterClose":4.4504,"fiveDayClose":4.1848,"twentyDayClose":4.1032,"sixtyDayClose":4.96},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GLMD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-19","symbol":"GLMD","defaultRemindTime":1787146200000,"type":"split","dateTimestamp":1787112000000,"forFactor":8,"toFactor":1,"ratio":8},{"market":"US","date":"2026-07-08","symbol":"GLMD","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1783483200000,"reportTimeType":"post","actualEps":-0.29},{"market":"US","date":"2026-03-31","symbol":"GLMD","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774929600000,"reportTimeType":"post","actualEps":-0.92},{"market":"US","date":"2025-11-26","symbol":"GLMD","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1764133200000,"reportTimeType":"pre","actualEps":-0.33},{"market":"US","date":"2025-08-28","symbol":"GLMD","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1756353600000,"reportTimeType":"pre","actualEps":0.63}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GLMD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GLMD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1743825600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GLMD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GLMD","date":"2026-08-21","current":-0.266727,"percent":0.770716,"low":-7.029466,"twenty":-0.93261,"median":-0.466939,"eighty":-0.327922,"high":-0.065822,"avg":-0.647567,"sd":0.511355,"marketCap":3761799},"quantilePoints":[{"date":"2021-08-27","current":-2.364142,"twenty":-12.657713,"median":-6.507712,"eighty":-3.642761,"marketCap":81522720},{"date":"2021-09-03","current":-2.269577,"twenty":-12.657713,"median":-6.507712,"eighty":-3.620978,"marketCap":78261811},{"date":"2021-09-10","current":-2.276851,"twenty":-12.657713,"median":-6.507712,"eighty":-3.610259,"marketCap":78512650},{"date":"2021-09-17","current":-2.218657,"twenty":-12.657713,"median":-6.507712,"eighty":-3.54877,"marketCap":76505937},{"date":"2021-09-24","current":-2.218657,"twenty":-12.657713,"median":-6.507712,"eighty":-3.504679,"marketCap":76505937},{"date":"2021-10-01","current":-1.98588,"twenty":-12.657713,"median":-6.507712,"eighty":-3.434603,"marketCap":68479085},{"date":"2021-10-08","current":-1.920411,"twenty":-12.653818,"median":-6.503896,"eighty":-3.408583,"marketCap":66221532},{"date":"2021-10-15","current":-2.000428,"twenty":-12.653818,"median":-6.503896,"eighty":-3.352577,"marketCap":68980763},{"date":"2021-10-22","current":-1.964057,"twenty":-12.653818,"median":-6.503896,"eighty":-3.300378,"marketCap":67726567},{"date":"2021-10-29","current":-1.796748,"twenty":-12.649924,"median":-6.503896,"eighty":-3.169826,"marketCap":61957267},{"date":"2021-11-05","current":-2.0368,"twenty":-12.649924,"median":-6.503896,"eighty":-3.144374,"marketCap":70234959},{"date":"2021-11-12","current":-2.139368,"twenty":-12.649924,"median":-6.503896,"eighty":-3.102477,"marketCap":75502581},{"date":"2021-11-19","current":-1.93325,"twenty":-12.649924,"median":-6.503896,"eighty":-3.08504,"marketCap":68228246},{"date":"2021-11-26","current":-1.876389,"twenty":-12.649924,"median":-6.503896,"eighty":-3.071968,"marketCap":66221532},{"date":"2021-12-03","current":-1.599195,"twenty":-12.649924,"median":-6.503896,"eighty":-3.061654,"marketCap":56438806},{"date":"2021-12-10","current":-1.627626,"twenty":-12.649924,"median":-6.503896,"eighty":-3.035255,"marketCap":57442163},{"date":"2021-12-17","current":-1.478367,"twenty":-12.649924,"median":-6.503896,"eighty":-3.002252,"marketCap":52174541},{"date":"2021-12-23","current":-1.44283,"twenty":-12.649924,"median":-6.503896,"eighty":-2.991174,"marketCap":50920345},{"date":"2021-12-31","current":-1.293571,"twenty":-12.649924,"median":-6.503896,"eighty":-2.982468,"marketCap":45652723},{"date":"2022-01-07","current":-1.33977,"twenty":-12.646029,"median":-6.503896,"eighty":-2.963268,"marketCap":47283177},{"date":"2022-01-14","current":-1.137206,"twenty":-12.646029,"median":-6.503896,"eighty":-2.934321,"marketCap":40134262},{"date":"2022-01-21","current":-1.093423,"twenty":-12.646029,"median":-6.503896,"eighty":-2.920688,"marketCap":38589093},{"date":"2022-01-28","current":-1.010123,"twenty":-12.646029,"median":-6.503896,"eighty":-2.914209,"marketCap":35649258},{"date":"2022-02-04","current":-1.172743,"twenty":-12.642135,"median":-6.497295,"eighty":-2.903251,"marketCap":41388458},{"date":"2022-02-11","current":-1.172743,"twenty":-12.642135,"median":-6.497295,"eighty":-2.877096,"marketCap":41388458},{"date":"2022-02-18","current":-1.158528,"twenty":-12.642135,"median":-6.497295,"eighty":-2.852985,"marketCap":40886779},{"date":"2022-02-25","current":-1.101597,"twenty":-12.642135,"median":-6.497295,"eighty":-2.842222,"marketCap":38877558},{"date":"2022-03-04","current":-0.95241,"twenty":-12.642135,"median":-6.482194,"eighty":-2.814018,"marketCap":33612444},{"date":"2022-03-11","current":-0.959517,"twenty":-12.642135,"median":-6.482194,"eighty":-2.789002,"marketCap":33863283},{"date":"2022-03-18","current":-1.108776,"twenty":-12.642135,"median":-6.478036,"eighty":-2.780436,"marketCap":39130905},{"date":"2022-03-25","current":-1.080345,"twenty":-12.642135,"median":-6.471571,"eighty":-2.768914,"marketCap":38127549},{"date":"2022-04-01","current":-1.172743,"twenty":-12.642135,"median":-6.471571,"eighty":-2.720522,"marketCap":41388458},{"date":"2022-04-08","current":-1.236711,"twenty":-12.642135,"median":-6.471571,"eighty":-2.704194,"marketCap":43646010},{"date":"2022-04-14","current":-1.158528,"twenty":-12.642135,"median":-6.46327,"eighty":-2.695876,"marketCap":40886779},{"date":"2022-04-22","current":-1.101668,"twenty":-12.642135,"median":-6.420822,"eighty":-2.662685,"marketCap":38880066},{"date":"2022-04-29","current":-1.179851,"twenty":-12.642135,"median":-6.358459,"eighty":-2.616654,"marketCap":41639297},{"date":"2022-05-06","current":-0.58728,"twenty":-12.642135,"median":-6.323924,"eighty":-2.584885,"marketCap":19067219},{"date":"2022-05-13","current":-0.469745,"twenty":-12.642135,"median":-6.308732,"eighty":-2.535577,"marketCap":15251221},{"date":"2022-05-20","current":-0.472123,"twenty":-12.642135,"median":-6.308732,"eighty":-2.497838,"marketCap":14024423},{"date":"2022-05-27","current":-0.430992,"twenty":-12.642135,"median":-6.308732,"eighty":-2.439573,"marketCap":12802617},{"date":"2022-06-03","current":-0.430739,"twenty":-12.642135,"median":-6.308732,"eighty":-2.380062,"marketCap":12795091},{"date":"2022-06-10","current":-0.46334,"twenty":-12.642135,"median":-6.308732,"eighty":-2.334595,"marketCap":13763503},{"date":"2022-06-17","current":-0.37204,"twenty":-12.642135,"median":-6.300511,"eighty":-2.316186,"marketCap":11051446},{"date":"2022-06-24","current":-0.407513,"twenty":-12.646029,"median":-6.222252,"eighty":-2.289945,"marketCap":12105159},{"date":"2022-07-01","current":-0.519589,"twenty":-12.646029,"median":-6.187588,"eighty":-2.25623,"marketCap":15434392},{"date":"2022-07-08","current":-0.51089,"twenty":-12.646029,"median":-6.152923,"eighty":-2.218657,"marketCap":15175981},{"date":"2022-07-15","current":-0.510805,"twenty":-12.646029,"median":-6.078785,"eighty":-2.197907,"marketCap":15173472},{"date":"2022-07-22","current":-0.487495,"twenty":-12.646029,"median":-6.012277,"eighty":-2.182186,"marketCap":14481032},{"date":"2022-07-29","current":-0.424066,"twenty":-12.646029,"median":-5.985674,"eighty":-2.171557,"marketCap":12596892},{"date":"2022-08-05","current":-0.441499,"twenty":-12.646029,"median":-5.912899,"eighty":-2.143296,"marketCap":11056464},{"date":"2022-08-12","current":-0.410881,"twenty":-12.646029,"median":-5.67974,"eighty":-2.114341,"marketCap":10289686},{"date":"2022-08-19","current":-0.457729,"twenty":-12.646029,"median":-5.599931,"eighty":-2.09938,"marketCap":11462896},{"date":"2022-08-26","current":-0.457127,"twenty":-12.646029,"median":-5.355613,"eighty":-2.086822,"marketCap":11447843},{"date":"2022-09-02","current":-0.450816,"twenty":-12.646029,"median":-5.232821,"eighty":-2.073171,"marketCap":11289786},{"date":"2022-09-09","current":-0.425771,"twenty":-12.646029,"median":-5.138128,"eighty":-2.06893,"marketCap":10662575},{"date":"2022-09-16","current":-0.43629,"twenty":-12.646029,"median":-4.96868,"eighty":-2.053589,"marketCap":10926004},{"date":"2022-09-23","current":-0.346627,"twenty":-12.646029,"median":-4.867653,"eighty":-2.041164,"marketCap":8680591},{"date":"2022-09-30","current":-0.311648,"twenty":-12.646029,"median":-4.803363,"eighty":-2.014977,"marketCap":7804604},{"date":"2022-10-07","current":-0.471153,"twenty":-12.646029,"median":-4.711521,"eighty":-1.996986,"marketCap":11799081},{"date":"2022-10-14","current":-0.389204,"twenty":-12.646029,"median":-4.674784,"eighty":-1.98588,"marketCap":9746848},{"date":"2022-10-21","current":-0.402228,"twenty":-12.646029,"median":-4.631552,"eighty":-1.977457,"marketCap":10072998},{"date":"2022-10-28","current":-0.400425,"twenty":-12.646029,"median":-4.564573,"eighty":-1.952814,"marketCap":10027839},{"date":"2022-11-04","current":-0.370871,"twenty":-12.646029,"median":-4.517831,"eighty":-1.920411,"marketCap":9287730},{"date":"2022-11-11","current":-0.34232,"twenty":-12.646029,"median":-4.481914,"eighty":-1.876487,"marketCap":8572711},{"date":"2022-11-18","current":-0.377734,"twenty":-12.646029,"median":-4.455801,"eighty":-1.797623,"marketCap":8566634},{"date":"2022-11-25","current":-0.333393,"twenty":-12.646029,"median":-4.435993,"eighty":-1.786521,"marketCap":7561018},{"date":"2022-12-02","current":-0.339839,"twenty":-12.646029,"median":-4.40844,"eighty":-1.720024,"marketCap":7707198},{"date":"2022-12-09","current":-0.32228,"twenty":-12.646029,"median":-4.371703,"eighty":-1.611989,"marketCap":7308984},{"date":"2022-12-16","current":-0.322391,"twenty":-12.646029,"median":-4.34208,"eighty":-1.475524,"marketCap":7311505},{"date":"2022-12-23","current":-0.597885,"twenty":-12.646029,"median":-4.297425,"eighty":-1.44283,"marketCap":13559427},{"date":"2022-12-30","current":-0.555655,"twenty":-12.646029,"median":-4.249035,"eighty":-1.361804,"marketCap":12601698},{"date":"2023-01-06","current":-0.889048,"twenty":-12.646029,"median":-4.197848,"eighty":-1.283621,"marketCap":20162716},{"date":"2023-01-13","current":-0.891048,"twenty":-12.646029,"median":-4.16965,"eighty":-1.231025,"marketCap":20208082},{"date":"2023-01-20","current":-0.834927,"twenty":-12.646029,"median":-4.151281,"eighty":-1.212546,"marketCap":18935311},{"date":"2023-01-27","current":-0.723574,"twenty":-12.646029,"median":-4.076423,"eighty":-1.179851,"marketCap":16409931},{"date":"2023-02-03","current":-0.78903,"twenty":-12.646029,"median":-3.970406,"eighty":-1.172743,"marketCap":17894411},{"date":"2023-02-10","current":-0.722351,"twenty":-12.646029,"median":-3.926486,"eighty":-1.162793,"marketCap":16382207},{"date":"2023-02-17","current":-0.644671,"twenty":-12.646029,"median":-3.804489,"eighty":-1.148578,"marketCap":14620490},{"date":"2023-02-24","current":-0.598996,"twenty":-12.646029,"median":-3.708518,"eighty":-1.137206,"marketCap":13584630},{"date":"2023-03-03","current":-0.577881,"twenty":-12.646029,"median":-3.668727,"eighty":-1.11304,"marketCap":13105765},{"date":"2023-03-10","current":-0.511203,"twenty":-12.646029,"median":-3.620978,"eighty":-1.101668,"marketCap":11593562},{"date":"2023-03-17","current":-0.519648,"twenty":-12.646029,"median":-3.577047,"eighty":-1.098782,"marketCap":11785107},{"date":"2023-03-24","current":-0.46675,"twenty":-12.646029,"median":-3.525355,"eighty":-1.08461,"marketCap":10585426},{"date":"2023-03-31","current":-0.601659,"twenty":-12.642135,"median":-3.478288,"eighty":-1.078241,"marketCap":10749248},{"date":"2023-04-06","current":-0.479635,"twenty":-12.642135,"median":-3.434603,"eighty":-1.059023,"marketCap":8569154},{"date":"2023-04-14","current":-0.451421,"twenty":-12.646029,"median":-3.391237,"eighty":-1.02775,"marketCap":8065086},{"date":"2023-04-21","current":-0.467644,"twenty":-12.646029,"median":-3.328928,"eighty":-0.987947,"marketCap":8354925},{"date":"2023-04-28","current":-0.423348,"twenty":-12.646029,"median":-3.200426,"eighty":-0.956674,"marketCap":7563539},{"date":"2023-05-05","current":-0.422925,"twenty":-12.646029,"median":-3.16227,"eighty":-0.910188,"marketCap":7555978},{"date":"2023-05-12","current":-0.50799,"twenty":-12.646029,"median":-3.119612,"eighty":-0.87002,"marketCap":9075742},{"date":"2023-05-19","current":-0.42979,"twenty":-12.646029,"median":-3.096347,"eighty":-0.805744,"marketCap":7678637},{"date":"2023-05-26","current":-0.479644,"twenty":-12.646029,"median":-3.079,"eighty":-0.777984,"marketCap":8569325},{"date":"2023-06-02","current":-0.435433,"twenty":-12.646029,"median":-3.065645,"eighty":-0.750401,"marketCap":7779451},{"date":"2023-06-09","current":-0.53743,"twenty":-12.646029,"median":-3.060183,"eighty":-0.709389,"marketCap":7283784},{"date":"2023-06-16","current":-0.462426,"twenty":-12.556452,"median":-3.030509,"eighty":-0.681251,"marketCap":6267265},{"date":"2023-06-23","current":-0.425854,"twenty":-12.412348,"median":-3.00059,"eighty":-0.656134,"marketCap":5771596},{"date":"2023-06-30","current":-0.369445,"twenty":-12.14751,"median":-2.988302,"eighty":-0.636536,"marketCap":5007091},{"date":"2023-07-07","current":-0.317376,"twenty":-12.018985,"median":-2.981717,"eighty":-0.603638,"marketCap":4301393},{"date":"2023-07-14","current":-0.257868,"twenty":-11.754148,"median":-2.955562,"eighty":-0.589688,"marketCap":3494882},{"date":"2023-07-21","current":-1.178447,"twenty":-11.462046,"median":-2.928615,"eighty":-0.589688,"marketCap":15971487},{"date":"2023-07-28","current":-1.102418,"twenty":-11.076473,"median":-2.920657,"eighty":-0.589688,"marketCap":14941069},{"date":"2023-08-04","current":-0.997878,"twenty":-9.887239,"median":-2.912699,"eighty":-0.589688,"marketCap":13524243},{"date":"2023-08-11","current":-0.15255,"twenty":-9.236087,"median":-2.896862,"eighty":-0.587352,"marketCap":1740896},{"date":"2023-08-18","current":-0.141537,"twenty":-9.074282,"median":-2.86495,"eighty":-0.559693,"marketCap":1615221},{"date":"2023-08-25","current":-0.144426,"twenty":-8.866779,"median":-2.85094,"eighty":-0.548981,"marketCap":1648185},{"date":"2023-08-31","current":-0.146213,"twenty":-8.813573,"median":-2.833503,"eighty":-0.53963,"marketCap":1668581},{"date":"2023-09-08","current":-0.145816,"twenty":-8.645974,"median":-2.797305,"eighty":-0.533429,"marketCap":1664049},{"date":"2023-09-15","current":-0.135562,"twenty":-8.550663,"median":-2.784739,"eighty":-0.522316,"marketCap":1547028},{"date":"2023-09-22","current":-0.108319,"twenty":-8.482121,"median":-2.776423,"eighty":-0.519589,"marketCap":1236139},{"date":"2023-09-29","current":-0.101459,"twenty":-8.437009,"median":-2.768108,"eighty":-0.515839,"marketCap":1157850},{"date":"2023-10-06","current":-0.080247,"twenty":-8.372453,"median":-2.721702,"eighty":-0.513131,"marketCap":915775},{"date":"2023-10-13","current":-0.081239,"twenty":-8.290678,"median":-2.705786,"eighty":-0.510924,"marketCap":927104},{"date":"2023-10-20","current":-0.077629,"twenty":-8.225087,"median":-2.689869,"eighty":-0.50743,"marketCap":885899},{"date":"2023-10-27","current":-0.066815,"twenty":-8.171859,"median":-2.669628,"eighty":-0.501201,"marketCap":762493},{"date":"2023-11-03","current":-0.138687,"twenty":-8.07667,"median":-2.622313,"eighty":-0.493086,"marketCap":1582698},{"date":"2023-11-10","current":-0.141953,"twenty":-7.924176,"median":-2.594371,"eighty":-0.482691,"marketCap":1619962},{"date":"2023-11-17","current":-0.141566,"twenty":-7.794678,"median":-2.550783,"eighty":-0.479414,"marketCap":1615554},{"date":"2023-11-24","current":-0.168516,"twenty":-7.742236,"median":-2.515053,"eighty":-0.476721,"marketCap":1269765},{"date":"2023-12-01","current":-0.188776,"twenty":-7.704228,"median":-2.45944,"eighty":-0.470923,"marketCap":1422425},{"date":"2023-12-08","current":-0.210525,"twenty":-7.648362,"median":-2.404209,"eighty":-0.467644,"marketCap":1586304},{"date":"2023-12-15","current":-0.193562,"twenty":-7.595156,"median":-2.342319,"eighty":-0.463641,"marketCap":1458486},{"date":"2023-12-22","current":-0.194678,"twenty":-7.249317,"median":-2.320497,"eighty":-0.461185,"marketCap":1466901},{"date":"2023-12-29","current":-0.231662,"twenty":-7.134924,"median":-2.305727,"eighty":-0.460706,"marketCap":1745576},{"date":"2024-01-05","current":-0.230413,"twenty":-7.016862,"median":-2.269577,"eighty":-0.457488,"marketCap":1736160},{"date":"2024-01-12","current":-0.239293,"twenty":-6.889176,"median":-2.225931,"eighty":-0.451177,"marketCap":1803074},{"date":"2024-01-19","current":-0.202123,"twenty":-6.845004,"median":-2.215019,"eighty":-0.447365,"marketCap":1522996},{"date":"2024-01-26","current":-0.194147,"twenty":-6.754852,"median":-2.196834,"eighty":-0.444528,"marketCap":1462894},{"date":"2024-02-02","current":-0.214796,"twenty":-6.545798,"median":-2.175011,"eighty":-0.44204,"marketCap":1618487},{"date":"2024-02-09","current":-0.18968,"twenty":-6.381296,"median":-2.153583,"eighty":-0.439184,"marketCap":1429236},{"date":"2024-02-16","current":-0.202123,"twenty":-6.177517,"median":-2.127307,"eighty":-0.437314,"marketCap":1522996},{"date":"2024-02-23","current":-0.191435,"twenty":-6.057502,"median":-2.110626,"eighty":-0.434681,"marketCap":1442459},{"date":"2024-03-01","current":-0.210791,"twenty":-5.985674,"median":-2.098937,"eighty":-0.430941,"marketCap":1588312},{"date":"2024-03-08","current":-0.20207,"twenty":-5.884583,"median":-2.086822,"eighty":-0.429768,"marketCap":1522596},{"date":"2024-03-15","current":-0.185585,"twenty":-5.599931,"median":-2.073171,"eighty":-0.426045,"marketCap":1398384},{"date":"2024-03-22","current":-0.168143,"twenty":-5.247881,"median":-2.064458,"eighty":-0.42332,"marketCap":1266960},{"date":"2024-03-28","current":-0.175588,"twenty":-4.93929,"median":-2.053216,"eighty":-0.422428,"marketCap":1323055},{"date":"2024-04-05","current":-0.263196,"twenty":-4.810711,"median":-2.0368,"eighty":-0.420562,"marketCap":1983185},{"date":"2024-04-12","current":-0.364735,"twenty":-4.724379,"median":-2.014977,"eighty":-0.416211,"marketCap":2521049},{"date":"2024-04-19","current":-0.329261,"twenty":-4.687207,"median":-1.993154,"eighty":-0.410746,"marketCap":2275855},{"date":"2024-04-26","current":-0.34126,"twenty":-4.657645,"median":-1.98588,"eighty":-0.4052,"marketCap":2358789},{"date":"2024-05-03","current":-0.334826,"twenty":-4.577431,"median":-1.97717,"eighty":-0.400285,"marketCap":2314317},{"date":"2024-05-10","current":-0.360823,"twenty":-4.52997,"median":-1.951051,"eighty":-0.390486,"marketCap":2494006},{"date":"2024-05-17","current":-0.346911,"twenty":-4.501725,"median":-1.920411,"eighty":-0.383454,"marketCap":2397851},{"date":"2024-05-24","current":-0.339086,"twenty":-4.463546,"median":-1.876471,"eighty":-0.380564,"marketCap":2343765},{"date":"2024-05-31","current":-0.349877,"twenty":-4.454362,"median":-1.80176,"eighty":-0.377504,"marketCap":2224171},{"date":"2024-06-07","current":-0.340093,"twenty":-4.420505,"median":-1.785801,"eighty":-0.372007,"marketCap":2161972},{"date":"2024-06-14","current":-0.332791,"twenty":-4.390072,"median":-1.720024,"eighty":-0.368701,"marketCap":2115553},{"date":"2024-06-21","current":-0.313886,"twenty":-4.362519,"median":-1.620518,"eighty":-0.364426,"marketCap":1995373},{"date":"2024-06-28","current":-0.275076,"twenty":-4.334966,"median":-1.478367,"eighty":-0.358973,"marketCap":1748660},{"date":"2024-07-05","current":-0.310485,"twenty":-4.281862,"median":-1.449937,"eighty":-0.355995,"marketCap":1973753},{"date":"2024-07-12","current":-0.300782,"twenty":-4.233101,"median":-1.364647,"eighty":-0.352156,"marketCap":1912073},{"date":"2024-07-19","current":-0.304383,"twenty":-4.174998,"median":-1.279356,"eighty":-0.348982,"marketCap":1934965},{"date":"2024-07-26","current":-0.313986,"twenty":-4.151281,"median":-1.225965,"eighty":-0.346059,"marketCap":1996009},{"date":"2024-08-02","current":-0.304883,"twenty":-4.0903,"median":-1.208281,"eighty":-0.344212,"marketCap":1938144},{"date":"2024-08-09","current":-0.29128,"twenty":-3.981589,"median":-1.179851,"eighty":-0.340561,"marketCap":1851665},{"date":"2024-08-16","current":-0.280077,"twenty":-3.927483,"median":-1.172743,"eighty":-0.339403,"marketCap":1780447},{"date":"2024-08-23","current":-0.300382,"twenty":-3.810667,"median":-1.165636,"eighty":-0.338429,"marketCap":1909530},{"date":"2024-08-30","current":-0.304444,"twenty":-3.704071,"median":-1.158528,"eighty":-0.336722,"marketCap":1791045},{"date":"2024-09-06","current":-0.272018,"twenty":-3.669273,"median":-1.144313,"eighty":-0.334772,"marketCap":1600282},{"date":"2024-09-13","current":-0.449732,"twenty":-3.622752,"median":-1.130929,"eighty":-0.334772,"marketCap":2645775},{"date":"2024-09-20","current":-2.3951,"twenty":-3.585317,"median":-1.115883,"eighty":-0.334772,"marketCap":14090375},{"date":"2024-09-27","current":-1.816178,"twenty":-3.529491,"median":-1.115883,"eighty":-0.334772,"marketCap":10684573},{"date":"2024-10-04","current":-1.075874,"twenty":-3.47649,"median":-1.115883,"eighty":-0.334772,"marketCap":6329366},{"date":"2024-10-11","current":-0.986218,"twenty":-3.424426,"median":-1.102418,"eighty":-0.334772,"marketCap":5801919},{"date":"2024-10-18","current":-0.97341,"twenty":-3.386155,"median":-1.101668,"eighty":-0.334772,"marketCap":5726569},{"date":"2024-10-25","current":-1.006711,"twenty":-3.324682,"median":-1.09456,"eighty":-0.334772,"marketCap":5922478},{"date":"2024-11-01","current":-0.82996,"twenty":-3.194912,"median":-1.087453,"eighty":-0.334772,"marketCap":4882654},{"date":"2024-11-08","current":-0.760797,"twenty":-3.16227,"median":-1.080345,"eighty":-0.334772,"marketCap":4475766},{"date":"2024-11-15","current":-0.698213,"twenty":-3.110857,"median":-1.06613,"eighty":-0.334772,"marketCap":4415498},{"date":"2024-11-22","current":-0.655319,"twenty":-3.09501,"median":-1.041254,"eighty":-0.334772,"marketCap":4144239},{"date":"2024-11-29","current":-0.681532,"twenty":-3.078172,"median":-1.027416,"eighty":-0.334772,"marketCap":4310008},{"date":"2024-12-06","current":-0.667234,"twenty":-3.064601,"median":-1.007382,"eighty":-0.334772,"marketCap":4219588},{"date":"2024-12-13","current":-0.707745,"twenty":-3.046396,"median":-0.999026,"eighty":-0.334772,"marketCap":4475778},{"date":"2024-12-20","current":-0.726809,"twenty":-3.008197,"median":-0.987947,"eighty":-0.334772,"marketCap":4596337},{"date":"2024-12-27","current":-0.743489,"twenty":-2.999588,"median":-0.97341,"eighty":-0.334772,"marketCap":4701827},{"date":"2025-01-03","current":-0.817362,"twenty":-2.985915,"median":-0.95241,"eighty":-0.334772,"marketCap":5168996},{"date":"2025-01-10","current":-0.691064,"twenty":-2.974152,"median":-0.934986,"eighty":-0.334746,"marketCap":4370288},{"date":"2025-01-17","current":-0.691064,"twenty":-2.944532,"median":-0.898362,"eighty":-0.334746,"marketCap":4370288},{"date":"2025-01-24","current":-0.69838,"twenty":-2.928615,"median":-0.887682,"eighty":-0.334746,"marketCap":4416553},{"date":"2025-01-31","current":-0.662468,"twenty":-2.920657,"median":-0.863485,"eighty":-0.334746,"marketCap":4189448},{"date":"2025-02-07","current":-0.626723,"twenty":-2.912407,"median":-0.828887,"eighty":-0.334746,"marketCap":3963399},{"date":"2025-02-14","current":-0.62434,"twenty":-2.889924,"median":-0.792623,"eighty":-0.334746,"marketCap":3948329},{"date":"2025-02-21","current":-0.644143,"twenty":-2.872238,"median":-0.787335,"eighty":-0.334746,"marketCap":4073560},{"date":"2025-02-28","current":-0.509957,"twenty":-2.85094,"median":-0.77576,"eighty":-0.334746,"marketCap":3224971},{"date":"2025-03-07","current":-0.449883,"twenty":-2.831641,"median":-0.755691,"eighty":-0.334719,"marketCap":2845057},{"date":"2025-03-14","current":-0.411517,"twenty":-2.792209,"median":-0.743489,"eighty":-0.334719,"marketCap":2602431},{"date":"2025-03-21","current":-0.538553,"twenty":-2.781192,"median":-0.731574,"eighty":-0.334719,"marketCap":3405810},{"date":"2025-03-28","current":-0.378894,"twenty":-2.774844,"median":-0.723574,"eighty":-0.334719,"marketCap":2396123},{"date":"2025-04-04","current":-0.402523,"twenty":-2.753874,"median":-0.714894,"eighty":-0.334719,"marketCap":3025765},{"date":"2025-04-11","current":-0.396515,"twenty":-2.714724,"median":-0.707013,"eighty":-0.334746,"marketCap":2980604},{"date":"2025-04-17","current":-0.414539,"twenty":-2.697828,"median":-0.700596,"eighty":-0.334746,"marketCap":3116086},{"date":"2025-04-25","current":-0.471613,"twenty":-2.680843,"median":-0.696013,"eighty":-0.334719,"marketCap":3545113},{"date":"2025-05-02","current":-0.375488,"twenty":-2.648486,"median":-0.691064,"eighty":-0.334719,"marketCap":2822542},{"date":"2025-05-09","current":-0.372484,"twenty":-2.602527,"median":-0.683915,"eighty":-0.334719,"marketCap":2799962},{"date":"2025-05-16","current":-0.357464,"twenty":-2.56925,"median":-0.681532,"eighty":-0.334719,"marketCap":2687060},{"date":"2025-05-23","current":-0.43341,"twenty":-2.51967,"median":-0.677899,"eighty":-0.334719,"marketCap":3183827},{"date":"2025-05-30","current":-0.439557,"twenty":-2.488192,"median":-0.667234,"eighty":-0.334719,"marketCap":3228988},{"date":"2025-06-06","current":-0.458,"twenty":-2.410557,"median":-0.657702,"eighty":-0.334719,"marketCap":3364470},{"date":"2025-06-13","current":-0.494886,"twenty":-2.375781,"median":-0.655319,"eighty":-0.334719,"marketCap":3635434},{"date":"2025-06-20","current":-0.547141,"twenty":-2.332797,"median":-0.643404,"eighty":-0.334692,"marketCap":4019300},{"date":"2025-06-27","current":-0.550215,"twenty":-2.313222,"median":-0.635533,"eighty":-0.334692,"marketCap":4041880},{"date":"2025-07-03","current":-0.560974,"twenty":-2.276851,"median":-0.630085,"eighty":-0.334692,"marketCap":4120912},{"date":"2025-07-11","current":-0.623987,"twenty":-2.25345,"median":-0.622972,"eighty":-0.334692,"marketCap":4583809},{"date":"2025-07-18","current":-0.716202,"twenty":-2.218657,"median":-0.616756,"eighty":-0.334692,"marketCap":5261219},{"date":"2025-07-25","current":-0.608618,"twenty":-2.196834,"median":-0.60466,"eighty":-0.334692,"marketCap":4470907},{"date":"2025-08-01","current":-1.211731,"twenty":-2.175011,"median":-0.601659,"eighty":-0.334692,"marketCap":8901376},{"date":"2025-08-08","current":-1.018449,"twenty":-2.153583,"median":-0.601659,"eighty":-0.334692,"marketCap":7481524},{"date":"2025-08-15","current":-1.100222,"twenty":-2.127307,"median":-0.601659,"eighty":-0.334692,"marketCap":8082231},{"date":"2025-08-22","current":-1.092788,"twenty":-2.109542,"median":-0.601659,"eighty":-0.334692,"marketCap":8027621},{"date":"2025-08-29","current":-0.864037,"twenty":-2.094994,"median":-0.601659,"eighty":-0.334692,"marketCap":7536134},{"date":"2025-09-05","current":-0.801426,"twenty":-2.08172,"median":-0.601659,"eighty":-0.334677,"marketCap":6990037},{"date":"2025-09-12","current":-0.970477,"twenty":-2.073171,"median":-0.601659,"eighty":-0.334692,"marketCap":8464498},{"date":"2025-09-19","current":-0.948594,"twenty":-2.063018,"median":-0.601659,"eighty":-0.334692,"marketCap":8273638},{"date":"2025-09-26","current":-0.866927,"twenty":-2.051348,"median":-0.601659,"eighty":-0.334692,"marketCap":7561338},{"date":"2025-10-03","current":-0.986287,"twenty":-2.0368,"median":-0.601659,"eighty":-0.334692,"marketCap":8602392},{"date":"2025-10-10","current":-0.976864,"twenty":-2.014977,"median":-0.601659,"eighty":-0.334692,"marketCap":8520204},{"date":"2025-10-17","current":-0.885773,"twenty":-1.993154,"median":-0.601659,"eighty":-0.334692,"marketCap":7725715},{"date":"2025-10-24","current":-0.857504,"twenty":-1.98588,"median":-0.601659,"eighty":-0.334692,"marketCap":7479150},{"date":"2025-10-31","current":-0.841799,"twenty":-1.975736,"median":-0.601659,"eighty":-0.334692,"marketCap":7342169},{"date":"2025-11-07","current":-0.774455,"twenty":-1.942234,"median":-0.601659,"eighty":-0.334692,"marketCap":6754795},{"date":"2025-11-14","current":-0.672183,"twenty":-1.920411,"median":-0.601659,"eighty":-0.334692,"marketCap":5862777},{"date":"2025-11-21","current":-0.511927,"twenty":-1.876553,"median":-0.600253,"eighty":-0.334692,"marketCap":4465025},{"date":"2025-11-28","current":-0.591946,"twenty":-1.805314,"median":-0.596815,"eighty":-0.334692,"marketCap":5149929},{"date":"2025-12-05","current":-0.71167,"twenty":-1.791099,"median":-0.595266,"eighty":-0.334692,"marketCap":6191531},{"date":"2025-12-12","current":-0.64869,"twenty":-1.757261,"median":-0.595266,"eighty":-0.334692,"marketCap":5643607},{"date":"2025-12-19","current":-0.559826,"twenty":-1.663163,"median":-0.591946,"eighty":-0.334692,"marketCap":4870488},{"date":"2025-12-26","current":-0.55441,"twenty":-1.620518,"median":-0.58719,"eighty":-0.334692,"marketCap":4823367},{"date":"2026-01-02","current":-0.472662,"twenty":-1.492582,"median":-0.578048,"eighty":-0.334692,"marketCap":4112162},{"date":"2026-01-09","current":-0.535264,"twenty":-1.457045,"median":-0.573961,"eighty":-0.334692,"marketCap":4656798},{"date":"2026-01-16","current":-0.493446,"twenty":-1.371754,"median":-0.561742,"eighty":-0.334692,"marketCap":4292977},{"date":"2026-01-23","current":-0.537154,"twenty":-1.330674,"median":-0.5579,"eighty":-0.334692,"marketCap":4673236},{"date":"2026-01-30","current":-0.472347,"twenty":-1.258034,"median":-0.55441,"eighty":-0.334692,"marketCap":4109423},{"date":"2026-02-06","current":-0.374729,"twenty":-1.232132,"median":-0.548981,"eighty":-0.334692,"marketCap":3260142},{"date":"2026-02-13","current":-0.383546,"twenty":-1.215389,"median":-0.547597,"eighty":-0.334692,"marketCap":3336851},{"date":"2026-02-20","current":-0.431951,"twenty":-1.208281,"median":-0.544453,"eighty":-0.334692,"marketCap":3757973},{"date":"2026-02-27","current":-0.491713,"twenty":-1.186958,"median":-0.538301,"eighty":-0.334692,"marketCap":4277903},{"date":"2026-03-06","current":-0.476583,"twenty":-1.178447,"median":-0.536618,"eighty":-0.334692,"marketCap":4146275},{"date":"2026-03-13","current":-0.492318,"twenty":-1.172743,"median":-0.532683,"eighty":-0.334692,"marketCap":4283168},{"date":"2026-03-20","current":-0.441407,"twenty":-1.158528,"median":-0.526034,"eighty":-0.334692,"marketCap":3840241},{"date":"2026-03-27","current":-0.444887,"twenty":-1.152259,"median":-0.523145,"eighty":-0.334692,"marketCap":3870515},{"date":"2026-04-02","current":-0.400935,"twenty":-1.144313,"median":-0.52076,"eighty":-0.334692,"marketCap":3488136},{"date":"2026-04-10","current":-0.501281,"twenty":-1.130929,"median":-0.518323,"eighty":-0.334615,"marketCap":5167707},{"date":"2026-04-17","current":-0.471786,"twenty":-1.108776,"median":-0.516183,"eighty":-0.334615,"marketCap":4863647},{"date":"2026-04-24","current":-0.392623,"twenty":-1.102418,"median":-0.514795,"eighty":-0.334615,"marketCap":4047554},{"date":"2026-05-01","current":-0.363895,"twenty":-1.101668,"median":-0.512126,"eighty":-0.334615,"marketCap":3751392},{"date":"2026-05-08","current":-0.399933,"twenty":-1.093423,"median":-0.511059,"eighty":-0.334615,"marketCap":4122911},{"date":"2026-05-15","current":-0.420394,"twenty":-1.087453,"median":-0.508765,"eighty":-0.334615,"marketCap":4333845},{"date":"2026-05-22","current":-0.370343,"twenty":-1.080345,"median":-0.503059,"eighty":-0.334615,"marketCap":3817864},{"date":"2026-05-29","current":-0.432524,"twenty":-1.076283,"median":-0.500488,"eighty":-0.334493,"marketCap":4458891},{"date":"2026-06-05","current":-0.466105,"twenty":-1.06613,"median":-0.498237,"eighty":-0.334615,"marketCap":4805072},{"date":"2026-06-12","current":-0.393198,"twenty":-1.055618,"median":-0.493384,"eighty":-0.333783,"marketCap":4053478},{"date":"2026-06-18","current":-0.383175,"twenty":-1.041254,"median":-0.491812,"eighty":-0.333783,"marketCap":3950150},{"date":"2026-06-26","current":-0.366129,"twenty":-1.026594,"median":-0.487495,"eighty":-0.333705,"marketCap":3774427},{"date":"2026-07-02","current":-0.413563,"twenty":-1.012822,"median":-0.483745,"eighty":-0.333705,"marketCap":4263424},{"date":"2026-07-10","current":-0.338444,"twenty":-1.002099,"median":-0.479776,"eighty":-0.333705,"marketCap":3761802},{"date":"2026-07-17","current":-0.326628,"twenty":-0.99562,"median":-0.47853,"eighty":-0.332755,"marketCap":3630469},{"date":"2026-07-24","current":-0.32835,"twenty":-0.986287,"median":-0.476583,"eighty":-0.330438,"marketCap":3649608},{"date":"2026-07-31","current":-0.355663,"twenty":-0.975243,"median":-0.473776,"eighty":-0.329418,"marketCap":3953192},{"date":"2026-08-07","current":-0.355663,"twenty":-0.960939,"median":-0.471699,"eighty":-0.329418,"marketCap":3953192},{"date":"2026-08-14","current":-0.315287,"twenty":-0.946697,"median":-0.470541,"eighty":-0.32897,"marketCap":3504416},{"date":"2026-08-21","current":-0.338443,"twenty":-0.93261,"median":-0.466939,"eighty":-0.327922,"marketCap":3761799}],"updateTime":1787475354213},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GLMD\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2627235186","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Galmed Pharmaceuticals (GLMD), Neurocrine (NBIX) and Mesoblast (MESO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2627235186","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627235186?lang=en_us&edition=fundamental","pubTime":"2026-04-15 23:00","pubTimestamp":1776265224,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Galmed Pharmaceuticals (GLMD), Neurocrine (NBIX) a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-galmed-pharmaceuticals-glmd-neurocrine-nbix-and-mesoblast-meso-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-galmed-pharmaceuticals-glmd-neurocrine-nbix-and-mesoblast-meso-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","LU2065169927.USD","BK4581","BK4137","LU0128526141.USD","XBI","LU0823416689.USD","XLV","LU2324357040.USD","LU2065170008.USD","LU0320765992.SGD","GLMD","LU2065171311.SGD","BK4588","LABU","LU0029874061.USD","BK4139","LU0109394709.USD","LU0154245756.USD","LU2065171402.SGD","BK4585","LU0889565916.HKD","LU0154245673.USD","NBIX","MESO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627441678","title":"BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Nano-X, Travere","url":"https://stock-news.laohu8.com/highlight/detail?id=2627441678","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627441678?lang=en_us&edition=fundamental","pubTime":"2026-04-14 21:15","pubTimestamp":1776172541,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Nano-X, TravereWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https:/","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nL6N40X0IU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRCE","CAT","F","SPOT","AVNS","TSLT","NWMX","TSLW","TSLL","BLK","AVXL","AAL","CRWG","CRWV","GM","LUV","DAL","EAF","TVTX","FRDU","CDE","KMX","TSLA","ORCL","HL","LCID","GSAT","UAL","NNOX","JNJ","DOW","CMPS","GLMD","NEM","WMG","AU","BE","BEZ","TE","ORCU","HOTH","TLA","TESL","TSLQ","CMND","CRDO","CWVX","ACI","TSLG","SPOG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627445597","title":"Galmed Pharmaceuticals Teams with Tel Aviv University on Aramchol for Metastatic Brain Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2627445597","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627445597?lang=en_us&edition=fundamental","pubTime":"2026-04-14 19:57","pubTimestamp":1776167861,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Galmed Pharmaceuticals ( ($GLMD) ). On April 14, 2026, Galmed Pharmaceuticals announced a research collaboratio...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/galmed-pharmaceuticals-teams-with-tel-aviv-university-on-aramchol-for-metastatic-brain-cancer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/galmed-pharmaceuticals-teams-with-tel-aviv-university-on-aramchol-for-metastatic-brain-cancer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","GLMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627443351","title":"Galmed partners with Tel Aviv University to test Aramchol in brain metastases","url":"https://stock-news.laohu8.com/highlight/detail?id=2627443351","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627443351?lang=en_us&edition=fundamental","pubTime":"2026-04-14 19:31","pubTimestamp":1776166305,"startTime":"0","endTime":"0","summary":"Galmed signed research collaboration agreement with Ramot at Tel Aviv University to evaluate brain-penetrant SCD1 inhibitor Aramchol as targeted therapy for metastatic brain cancer.Program targets p53-deficient brain metastases based on TAU findings linking p53 inactivation to SCD1 upregulation that supports tumor growth in brain.Work will use TAU 3D in vitro systems plus in vivo brain-metastasis models to assess Aramchol efficacy.Collaboration aims to support Galmed oncology development strategy, including ongoing clinical work in colorectal cancer where p53 mutations are common.Galmed said overall 2-year survival for brain metastasis remains below 10%, underscoring need for new targeted therapies.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nNDL89MDC5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GLMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627480164","title":"Galmed Announces a Collaboration Agreement With Tel Aviv University to Evaluate Its Scd1 Inhibitor, Aramchol, as a Targeted Therapy for Metastatic Brain Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2627480164","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627480164?lang=en_us&edition=fundamental","pubTime":"2026-04-14 19:30","pubTimestamp":1776166200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nTUABQXJVN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GLMD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626231134","title":"BUZZ-U.S. STOCKS ON THE MOVE-Amazon, Northrop Grumman, Brown-Forman","url":"https://stock-news.laohu8.com/highlight/detail?id=2626231134","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626231134?lang=en_us&edition=fundamental","pubTime":"2026-04-10 01:51","pubTimestamp":1775757106,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Amazon, Northrop Grumman, Brown-FormanWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call new","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nL6N40S0MV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLSX","AZYY","HRL","OXY","WSR","CAT","CCCC","CRWG","STAA","CRWV","NRGV","TSLI","TSLS","NOC","TSLA","NOW","MVLL","WW","GLMD","CRWU","TSLG","CG","AMZN","IDYA","CORD","TSLR","TSLL","SMPL","STZ","ANVS","VNDA","NUAI","TEMT","APLD","BLSG","TEM","TSL","TSLP","TSLO","CRSH","TSLQ","RELL","GDRX","FDX","MRVL","BLSH","MRVU","FBRX","ADSK","KYMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626824561","title":"Why Is Galmed Pharmaceuticals Stock (GLMD) Up Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2626824561","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626824561?lang=en_us&edition=fundamental","pubTime":"2026-04-09 20:36","pubTimestamp":1775738206,"startTime":"0","endTime":"0","summary":"Galmed Pharmaceuticals stock took off today alongside an update on the company’s Parkinson disease treatment, Aramchol.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-is-galmed-pharmaceuticals-stock-glmd-up-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-is-galmed-pharmaceuticals-stock-glmd-up-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLMD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626845201","title":"BUZZ-Galmed jumps on lab data on new brain-penetrating version of experimental drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2626845201","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626845201?lang=en_us&edition=fundamental","pubTime":"2026-04-09 20:05","pubTimestamp":1775736348,"startTime":"0","endTime":"0","summary":"BUZZ-Galmed jumps on lab data on new brain-penetrating version of experimental drug** Shares of biotech firm Galmed Pharmaceuticals GLMD.O jump 68% to $1.05 premarket** Co says it developed a new formulation of its experimental drug Aramchol that can reach the brain, targeting Parkinson's and similar brain diseases that affect movement and thinking** Co says lab tests showed the new version lowered levels of a disease-linked protein and was not toxic in early studies** The new formulation uses tiny fat-based particles to help the drug cross the brain's natural protective barrier, co says** Co plans early-stage human trials in the second half of 2026, pending regulatory approval - GLMD** Parkinson's is a brain disorder where harmful proteins build up and slowly damage nerve cells; there are no treatments that slow the disease** As of last close, stock was down ~17% YTD  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nL4N40S0YZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLMD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626218977","title":"Galmed Pharmaceuticals Ltd - Develops Brain-Penetrating Formulation of Aramchol With Barcode Nanotech","url":"https://stock-news.laohu8.com/highlight/detail?id=2626218977","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626218977?lang=en_us&edition=fundamental","pubTime":"2026-04-09 19:34","pubTimestamp":1775734498,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nFWN40S0L0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GLMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626918971","title":"Galmed plans Phase 1b/2 Parkinson’s trial for brain-penetrating Aramchol in H2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2626918971","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626918971?lang=en_us&edition=fundamental","pubTime":"2026-04-09 19:32","pubTimestamp":1775734353,"startTime":"0","endTime":"0","summary":"Galmed unveiled a brain-penetrating formulation of Aramchol that it aims to advance into a proof-of-concept Phase 1b/2 study in Parkinson disease patients in H2 2026.Results have not been presented; preliminary in-vitro findings were referenced, with Aramchol described as reducing alpha-synuclein aggregation without signs of toxicity.Program targets synucleinopathies where no disease-modifying therapies are available, positioning Aramchol as a potential first-in-class SCD1 inhibitor for central nervous system use.Delivery strategy uses lipid nanoparticles designed to cross blood-brain barrier, with subcutaneous administration planned.Development work was conducted with Barcode Nanotech, using in vivo screening and AI tools to select formulation intended to improve brain delivery.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDL8BSnc2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GLMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624300530","title":"Galmed net loss widens 37% to $10 million in FY25","url":"https://stock-news.laohu8.com/highlight/detail?id=2624300530","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624300530?lang=en_us&edition=fundamental","pubTime":"2026-04-01 04:23","pubTimestamp":1774988611,"startTime":"0","endTime":"0","summary":"Galmed Pharmaceuticals widened net loss 37% to $10.3 million for the year ended Dec. 31, 2025.Research and development expense jumped 64% to $4.9 million, due to higher clinical trial costs.Cash and cash equivalents totaled $4.0 million, while current assets rose to $18.6 million.Galmed said existing funds should support operations for more than 12 months from the annual report’s issuance date.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Galmed Pharmaceuticals Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 31, 2026, and is solely responsible for the information contained th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDLbgTccv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GLMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622821993","title":"Galmed Pharmaceuticals Ltd  expected to post a loss of 51 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2622821993","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622821993?lang=en_us&edition=fundamental","pubTime":"2026-03-27 20:44","pubTimestamp":1774615449,"startTime":"0","endTime":"0","summary":"Galmed Pharmaceuticals Ltd  expected to post a loss of51cents a share - Earnings Preview Galmed Pharmaceuticals Ltd GLMD.OQ GLMD.O is expected to  report resultson March 31 (estimated) for the period ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nL8N40F10T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLMD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620325863","title":"Galmed Pharmaceuticals Ltd. CFO Doron Leib Cohen files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620325863","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620325863?lang=en_us&edition=fundamental","pubTime":"2026-03-18 19:46","pubTimestamp":1773834392,"startTime":"0","endTime":"0","summary":"Galmed reported an initial statement of beneficial ownership by Doron Leib Cohen, its Chief Financial Officer. Cohen reported direct beneficial ownership of 22,083 ordinary shares. Cohen also reported direct beneficial ownership of 50,416 restricted share units. Cohen reported options to purchase 208 ordinary shares at an exercise price of USD 68.4.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Galmed Pharmaceuticals Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL8Wx2Cy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GLMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620258686","title":"Galmed Pharmaceuticals COO Nehemya Guy files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620258686","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620258686?lang=en_us&edition=fundamental","pubTime":"2026-03-18 19:46","pubTimestamp":1773834389,"startTime":"0","endTime":"0","summary":"Galmed reported an initial statement of beneficial ownership for Nehemya Guy, its chief operating officer. Guy reported direct ownership of 22,116 ordinary shares. He also reported direct ownership of 50,416 restricted share units. Guy reported options to purchase 666 ordinary shares at an exercise price of USD 68.4.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Galmed Pharmaceuticals Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL221wjB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLMD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620258636","title":"Galmed Pharmaceuticals names Chief Accounting Officer Yohai Stenzler in initial beneficial ownership filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2620258636","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620258636?lang=en_us&edition=fundamental","pubTime":"2026-03-18 19:46","pubTimestamp":1773834388,"startTime":"0","endTime":"0","summary":"Galmed reported an initial statement of beneficial ownership by Yohai Stenzler, its chief accounting officer. Stenzler reported direct ownership of 22,116 ordinary shares. He also reported direct ownership of restricted share units totaling 50,416. Stenzler reported options to purchase 777 ordinary shares with an exercise price of USD 68.4.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Galmed Pharmaceuticals Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL8b2RrK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GLMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620258507","title":"Galmed Pharmaceuticals Director Carol L. Brosgart Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620258507","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620258507?lang=en_us&edition=fundamental","pubTime":"2026-03-18 19:46","pubTimestamp":1773834386,"startTime":"0","endTime":"0","summary":"Galmed reported an initial statement of beneficial ownership by Carol Brosgart, a director. The filing listed options to purchase ordinary shares totaling 36,693 shares. It included an option grant for 17,500 shares with an exercise price of USD 2.88. It also included an option grant for 12,500 shares with an exercise price of USD 1.41.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Galmed Pharmaceuticals Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL50Y4CL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLMD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620258509","title":"Galmed Pharmaceuticals names CEO Allen Baharaff in initial beneficial ownership filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2620258509","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620258509?lang=en_us&edition=fundamental","pubTime":"2026-03-18 19:46","pubTimestamp":1773834385,"startTime":"0","endTime":"0","summary":"Allen Baharaff, chief executive officer and a director of Galmed, filed an initial statement of beneficial ownership. The filing reported 103,047 ordinary shares held directly. It also reported 205,555 restricted share units held directly. The filing listed options to purchase 5,471 ordinary shares at exercise prices ranging from USD 0 to USD 2,081.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Galmed Pharmaceuticals Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL5lYb00:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GLMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617562599","title":"Galmed Pharmaceuticals Adjourns Special Shareholder Meeting for Lack of Quorum","url":"https://stock-news.laohu8.com/highlight/detail?id=2617562599","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617562599?lang=en_us&edition=fundamental","pubTime":"2026-03-05 06:08","pubTimestamp":1772662104,"startTime":"0","endTime":"0","summary":"Galmed Pharmaceuticals ( ($GLMD) ) just unveiled an announcement. On March 4, 2026, Galmed Pharmaceuticals convened a Special General Meeting of Sh...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/galmed-pharmaceuticals-adjourns-special-shareholder-meeting-for-lack-of-quorum?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/galmed-pharmaceuticals-adjourns-special-shareholder-meeting-for-lack-of-quorum?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","GLMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617569222","title":"Galmed Pharmaceuticals Delays Shareholder Meeting to March 5","url":"https://stock-news.laohu8.com/highlight/detail?id=2617569222","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617569222?lang=en_us&edition=fundamental","pubTime":"2026-03-05 05:18","pubTimestamp":1772659080,"startTime":"0","endTime":"0","summary":"Galmed Pharmaceuticals Ltd. said its Special General Meeting of Shareholders convened on March 4, 2026 was adjourned for one day due to a lack of quorum. The company said the meeting will be reconvened on March 5, 2026 at 4:00 p.m. Israel time at the offices of Meitar | Law Offices in Ramat Gan, Israel.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Galmed Pharmaceuticals Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 04, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nNDL192BQp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GLMD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":59,"code":"91000000","status":"200"}]}}